Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2006
09/14/2006US20060204518 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
09/14/2006US20060204517 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
09/14/2006US20060204490 Hemostatic compositions containing sterile thrombin
09/14/2006US20060204451 Chewing gum in the form of multi-layer tablets
09/14/2006US20060204450 Pharmaceutical Compositions Based On Anticholinergics and PDE 5-Inhibitors
09/14/2006US20060204449 Nasal pharmaceutical composition of piribedil
09/14/2006US20060204448 Powdery preparation for nasal administration
09/14/2006US20060204447 Delivering, via small particle aerosol, aqueous dispersions of anti-cancer drugs in liposomes or lipid complexes to respiratory tract of an individual in need of such treatment
09/14/2006US20060204446 Topical immunotherapy and compositions for use therein
09/14/2006US20060204442 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
09/14/2006US20060204440 Radio-opaque polymeric biomaterials
09/14/2006US20060201886 Method for determining the binding behavior of ligands which specifically bind to target molecules
09/14/2006DE102005011786A1 Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen A process for the production of ultrafine submicron suspensions
09/14/2006DE102005011367A1 Verfahren zur Herstellung von Cellulosesulfat mit verbesserten Eigenschaften A process for the production of cellulose sulfate with improved characteristics
09/14/2006DE102005011029A1 Zusammensetzung für die perorale Applikation mit gesteuerter Freisetzung von Wirkstoffen A composition for oral administration with controlled release of active ingredients
09/14/2006DE102005010419A1 Active agent application device, useful as wound cover, comprises edition part for edition on skin and/or tissue from liquid storing and delivering material, covering layer, feeding equipment that has tube section and connecting substance
09/14/2006DE102005005173A1 Wirkstoffhaltige Selbstklebemassen und deren Herstellung Active ingredient-containing self-adhesive compositions and their preparation
09/14/2006CA2745782A1 Pharmaceutical compositions and uses for peptide treatment
09/14/2006CA2623112A1 Method for producing ultrafine submicronic suspensions
09/14/2006CA2602007A1 Particle and preparation containing the particle
09/14/2006CA2601114A1 Pharmacological, chemical, and topical agent enhancement apparatus and method for using same
09/14/2006CA2601011A1 Sugar-coated pill
09/14/2006CA2600969A1 Soft gelatin capsules containing cyclodextrin in the capusle shell
09/14/2006CA2600638A1 Composition comprising emodepside and praziquantel or epsiprantel
09/14/2006CA2600370A1 Bioactive fus1 peptides and nanoparticle-polypeptide complexes
09/14/2006CA2600178A1 Novel method for obtaining a fast-dissolving imidapril powder
09/14/2006CA2600085A1 Microparticle and pharmaceutical preparation
09/14/2006CA2599968A1 Topical gels compositions
09/14/2006CA2599758A1 Pharmaceutical compositions comprising sirolimus and/or an analogue thereof
09/14/2006CA2599733A1 Methods and compositons for modified release of nutritional supplements
09/14/2006CA2599699A1 Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
09/14/2006CA2599697A1 Chemically defined stabiliser composition
09/14/2006CA2599290A1 Ketoprofen sis adhesive for skin adhesive plaster
09/14/2006CA2599251A1 Microemulsions of cannabinoid receptor binding compounds
09/14/2006CA2598503A1 New ophthalmologic compositions and their method of use
09/14/2006CA2598353A1 Non-fibrous transdermal therapeutic system and method for its production
09/14/2006CA2598288A1 Nanoparticulate compositions of heterocyclic amide derivatives
09/14/2006CA2596031A1 Injectable preparations of diclofenic and its pharmaceutically acceptable salts
09/14/2006CA2595033A1 Gastroresistant pharmaceutical formulations containing rifaximin
09/13/2006EP1700616A1 Compounds for the treatment of ocular dryness caused by photorefractive surgery
09/13/2006EP1700615A1 Device for intradermal medicament delivery
09/13/2006EP1700605A2 Lyophilized methionine-containing protein preparations stabilized over long time
09/13/2006EP1700603A2 Immunostimulatory nucleic acids
09/13/2006EP1700602A1 Pharmaceutical composition for use in hormone replacement therapy
09/13/2006EP1700597A1 Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application
09/13/2006EP1700595A1 Tablets having an emulsified polymer matrix for the controlled emission of gas, and production process
09/13/2006EP1700593A1 Water-in-Oil dispersion comprising dextran fatty acid ester
09/13/2006EP1700591A1 Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing
09/13/2006EP1699847A1 Medicinal compositions and method for the preparation thereof
09/13/2006EP1699837A1 Stereocomplex hydrogels with tunable degradation times
09/13/2006EP1699549A2 Systems for preparing fine particles and other substances
09/13/2006EP1699529A1 Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent
09/13/2006EP1699500A1 Crosslinked hyaluronic acid compositions for tissue augmentation
09/13/2006EP1699474A2 Probiotic tablet formulations
09/13/2006EP1699465A1 Treatment
09/13/2006EP1699458A1 Pharmaceutical composition
09/13/2006EP1699446A1 Compositions and methods for treating hepatitis c virus (hcv) infection
09/13/2006EP1699445A1 Collagen and polysaccharide-based coating composition
09/13/2006EP1699443A2 Pharmaceutical formulations of bisphosphonates
09/13/2006EP1699442A2 Enteric coated aliphatic amine polymer bile acid sequestrants
09/13/2006EP1699441A2 Fast-disintegrating tablets
09/13/2006EP1699440A1 Method for the production of an administration form which is secured against misuse
09/13/2006EP1699439A2 Controlled-release pharmaceutical formulation
09/13/2006EP1699438A2 Pharmaceutical preparation containing gabapentin
09/13/2006EP1699437A2 Method for preparing solid dosage form of desmopressin
09/13/2006EP1699436A2 Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
09/13/2006EP1699435A1 Particles
09/13/2006EP1699434A1 Process for preparing a medicament
09/13/2006EP1699433A2 Oleaginous pharmaceutical and cosmetic foam
09/13/2006EP1699432A2 Injectable phosphatidylcholine preparations
09/13/2006EP1699431A2 Compositions for treatment of ear disorders and methods of use thereof
09/13/2006EP1699430A1 Patch
09/13/2006EP1699393A2 Drug delivery device with mechanical locking mechanism
09/13/2006EP1699309A1 Inhaler for basic pharmaceutical agents and method for production thereof
09/13/2006EP1628642B1 Controlled drug release composition resistant to in vivo mechanic stress
09/13/2006EP1578325A4 Stable topical drug delivery compositions
09/13/2006EP1485067B1 Materials containing multiple layers of vesicles
09/13/2006EP1395252B1 Medicaments for treating colics
09/13/2006EP1385452B1 Ophthalmic drug delivery device
09/13/2006EP1360958B1 Liposomic formulation of clobetasol propionate
09/13/2006EP1331948B1 Pharmaceutical composition containing honey for the treatment of wounds
09/13/2006EP1296645B1 Methods for treating inflammation-mediated conditions of the eye
09/13/2006EP1274406B1 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
09/13/2006EP1267843B1 System for transporting active substances in a biological system
09/13/2006EP1246617B1 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of ovarian cancer
09/13/2006EP1227801B1 Multi-layer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients
09/13/2006EP1200067B1 Method for the preparation of microparticles comprising biological material
09/13/2006EP1196431B1 A substantially crystalline form of melagatran
09/13/2006EP1196146B1 Powder particles with smooth surface for use in inhalation therapy
09/13/2006EP1179344B1 Release-regulating preparations
09/13/2006EP1165126B1 Process for preparing a human papillomavirus vaccine with disassembled and reassembled virus-like particles
09/13/2006EP1079807B1 Use of preparations for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract
09/13/2006EP1071402B1 Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants
09/13/2006EP0965340B1 Dermatologic preparation
09/13/2006EP0957817B1 Locking couplings for osmotic delivery devices
09/13/2006EP0939608B1 Device and gel for acidic buffering
09/13/2006EP0921774B1 Transdermal drug delivery matrix for coadministering estradiol and another steroid
09/13/2006EP0813399B1 Form of administration for applying pharmaceutical substances and auxiliary substances, and process for the preparation thereof
09/13/2006CN2815405Y Medicine plaster for gynecology department
09/13/2006CN2815404Y Perfume health-care chain essential oil bag